Attention deficit hyperactivity disorder (ADHD) is the most common disability diagnosis in children globally. It's estimated ...
Co-occurring ADHD and substance use create unique challenges. The latest research shows what effective treatment really requires.
From December 1, specialist general practitioners will have the ability to diagnose adults with ADHD and prescribe medication ...
In two newly published studies, researchers at the Department of Ethology, Eötvös Loránd University (Hungary) investigated ...
Groundbreaking research has uncovered a set of just three gene variants that can increase the likelihood of attention-deficit ...
A new study suggests the connection between Attention-Deficit/Hyperactivity Disorder (ADHD) and the body’s primary stress ...
Adoptees’ higher ADHD rates reflect genetic, prenatal, and social factors, highlighting the need for trauma-informed, ...
Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...
Pfizer (PFE) stock is in focus as the firm joins Tris Pharma to settle a lawsuit over supplying an adulterated ADHD drug to ...
Shreveport Times on MSN
ADHD medicine not working like it should? It could be mislabeled bottles from August recall
Two manufacturers have issued recalls for generic Adderall, one over unknown impurities and the other over bottle mislabeling ...
Pfizer Inc. and Tris Pharma Inc. will pay the state of Texas $41.5 million to settle claims that it allegedly provided ...
Attention-deficit/hyperactivity disorder (ADHD) symptoms are influenced by socioeconomic factors in regions affected by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback